NorthStar Medical Radioisotopes
Total Raised
$193.74MInvestors Count
6Deal Terms
1Funding, Valuation & Revenue
7 Fundings
NorthStar Medical Radioisotopes has raised $193.74M over 7 rounds.
NorthStar Medical Radioisotopes's latest funding round was a Grant - IV for $37M on August 30, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/30/2021 | Grant - IV | $37M | 5 | |||
7/23/2019 | Grant - III | |||||
4/23/2019 | Unattributed | |||||
12/20/2016 | Grant - II | |||||
10/21/2015 | Grant |
Date | 8/30/2021 | 7/23/2019 | 4/23/2019 | 12/20/2016 | 10/21/2015 |
|---|---|---|---|---|---|
Round | Grant - IV | Grant - III | Unattributed | Grant - II | Grant |
Amount | $37M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 5 |
NorthStar Medical Radioisotopes Deal Terms
1 Deal Term
NorthStar Medical Radioisotopes's deal structure is available for 1 funding round, including their Series A from April 11, 2012.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
NorthStar Medical Radioisotopes Investors
6 Investors
NorthStar Medical Radioisotopes has 6 investors. NNSA invested in NorthStar Medical Radioisotopes's Grant - IV funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/30/2021 | 8/30/2021 | 1 Grant - IV | Government | DC | ||
Government | DC | |||||
Debt & Specialty Finance | New York | |||||
Asset/Investment Management | ||||||
Incubator/Accelerator | Missouri |
First funding | 8/30/2021 | ||||
|---|---|---|---|---|---|
Last Funding | 8/30/2021 | ||||
Investor | |||||
Rounds | 1 Grant - IV | ||||
Board Seats | |||||
Type | Government | Government | Debt & Specialty Finance | Asset/Investment Management | Incubator/Accelerator |
Location | DC | DC | New York | Missouri |
Compare NorthStar Medical Radioisotopes to Competitors
Bayer HealthCare is a corporation based out of Germany.
Grupo Elfa is a company that provides healthcare logistics solutions and services within the healthcare sector. They offer a range of products and services, including the distribution of medications and the provision of medical-hospital products. The company primarily serves the healthcare industry, offering solutions tailored to meet the needs of their business. It was founded in 1990 and is based in Joao Pessoa, Brazil.
Curium operates in nuclear medicine, specializing in the development, manufacturing, and distribution of radiopharmaceutical products for diagnostics and treatment. The company focuses on nuclear solutions for cancer diagnostics and therapy, particularly in Neuroendocrine Tumors and prostate cancer. Curium is involved in expanding its oncology-focused nuclear medicine offerings and using AI to enhance medical imaging and diagnosis. It was founded in 2017 and is based in Paris, France.
Bracco operates in diagnostic imaging, focusing on the development, manufacture, and marketing of contrast agents and medical devices in the healthcare sector. The company offers a variety of products and solutions aimed at improving biomedical imaging accuracy and patient care in medical fields such as cardiology and radiology. Bracco's portfolio includes contrast agents for X-Ray/ computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine, along with administration systems developed by its subsidiary ACIST. It was founded in 1927 and is based in Milan, Italy.
Intelerad specializes in healthcare technology with a focus on medical imaging. The company offers a medical imaging platform that connects clinicians to an imaging ecosystem and provides access to clinical data, regardless of clinician location. It was founded in 1999 and is based in Raleigh, North Carolina. In November 2025, Intelerad was acquired by GE Healthcare at a valuation of $2.3B.
Agfa is a company that develops, manufactures and distributes analogue and digital imaging systems and IT solutions across various sectors. The company's offerings include products and services for the printing industry, healthcare sector, and specific industrial applications for business-to-business markets. Their technology is involved in activities such as reading newspapers or visiting hospitals. It was founded in 1964 and is based in Ridgefield Park, New Jersey.
Loading...